Singapore - englanti - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - clinical chemistry - for home (lay user) or professional use in the management of patients with diabetes. • for self testing or healthcare professional use outside the body (in vitro diagnostic use). • for monitoring glucose in fresh whole blood (e.g. fingertip). • for monitoring β-ketone in fresh whole blood from the fingertip. • measures β-hydroxybutyrate (β-ketone) • for use with optium or optium poc blood glucose test strips and optium ketone blood β-ketone test strips. • optium and optium poc blood glucose test strips are different. please refer to your test strip instructions for important information • optium poc blood glucose test strips are for use by healthcare professionals only.

Singapore - englanti - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - immunology - the abbott prismr hbcore assay is an in vitro chemiluminescent immunoassay (chlia) for the qualitative detection of total antibody to hepatitis b core antigen (anti-hbc) in human serum and plasma. it is intended to be used as a screen for blood and plasma to prevent transmission of hepatitis b virus (hbv) to recipients of blood and blood components and as an aid in the diagnosis of hbv infection. it is also intended for use in testing serum and plasma specimens to screen cell, tissue and organ donors when specimens are obtained while the donor’s heart is still beating. use with abbott prism system.

Singapore - englanti - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - immunology - the abbott prismr hbsag assay is an in vitro chemiluminescentimmunoassay (chlia) for the qualitative detection of hepatitis b surface antigen (hbsag) in human serum or plasma. it is intended as a screen for donated blood to prevent transmission of hepatitis b virus (hbv) to recipients of blood and blood components and as an aid in the diagnosis of ongoing or previous hepatitis b viral infection. use with abbott prism system. it is also intended for use in testing serum and plasma specimens to screen cell, tissue and organ donors when specimens are obtained while the donor’s heart is still beating.

Singapore - englanti - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - immunology - the abbott prismr htlv-i/htlv-ii assay is an in vitro chemiluminescent immunoassay (chlia) for the qualitative detection of antibodies to human t-lymphotropic virus type i and/or human t-lymphotropic virus type ii (anti-htlv-i/htlv-ii) in human serum or plasma. the abbott prism htlv-i/htlv-ii (chlia) is intended as a screen for donated blood to prevent transmission of htlv-i and htlv-ii to recipients of blood and blood components and as an aid in the diagnosis of htlv-i and htlv-ii infections. it is also intended for use in testing serum and plasma specimens to screen cell, tissue and organ donors when specimens are obtained while the donor’s heart is still beating. use with abbott prism system.

Singapore - englanti - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - immunology - the architect anti-hbe assay is a chemiluminescent microparticle immunoassay (cmia) for the qualitative detection of antibody to hepatitis b e antigen in human serum and plasma and is indicated for use as an aid in the diagnosis and monitoring of hepatitis b viral infection. use with abbott architect i2000 system and abbott architect i2000sr system.

Singapore - englanti - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - immunology - the architect hbeag assay is a chemiluminescent microparticle immunoassay (cmia) for the qualitative detection of hepatitis b e antigen in human serum and plasma and is indicated for use as an aid in the diagnosis and monitoring of hepatitis b viral infection. use with abbott architect i2000 system and abbott architect i2000sr system. the architect hbeag assay can also be used for the quantitative determination of hbeag. refer to architect hbeag quantitative calibrators package insert (7p24-01) for instructions and further information.

Singapore - englanti - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - immunology - the architect hbsag confirmatory v.1 assay is a chemiluminescent microparticle immunoassay (cmia) for the confirmation of the presence of hepatitis b surface antigen (hbsag) in human serum and plasma by means of specific antibody neutralization. use with abbott architect i2000 system and abbott architect i2000sr system.

Singapore - englanti - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - immunology - the architect free psa assay is a chemiluminescent microparticle immunoassay (cmia) for the quantitative determination of free prostate specific antigen (psa) in human serum. it is intended to be used in conjunction with architect total psa assay in men aged 50 years or older with total psa values between 4 and 10 ng/ml and dre non-suspicious for cancer to determine the ratio of free psa to total psa. can be used as an aid in discriminating between prostate cancer and benign disease. use with abbott architect i2000 system and abbott architect i2000sr system.

Singapore - englanti - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - immunology - abbott hemoglobin a1c assay is used in clinical laboratories for the quantitative in vitro measurement of percent hemoglobin a1c or hba1c fraction in human whole blood and hemolysate on the architect c 8000 and c 4000 systems. hemoglobin a1c measurements are used as an aid in the diagnosis of diabetes mellitus, to identify patients who may be at risk for developing diabetes mellitus, and for the monitoring of long-term blood glucose control in individuals with diabetes mellitus.

Singapore - englanti - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - immunology - abbott architect anti-hbs assay is a chemiluminescent microparticle immunoassay (cmia) for the quantitative determination of antibody to hepatitis b surface antigen (anti-hbs) in human serum or plasma. this assay can be run on the i2000, i2000sr and/or ci8200 analyzers.